Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
RepSox ALK5 Inhibitor for iPSC Research
2026-09-25
RepSox offers a controllable way to test ALK5 inhibition in stem-cell workflows, including exploratory studies of megakaryocyte and platelet differentiation. A 2026 hiPSC study provides a useful process benchmark—but did not test RepSox, so its results should guide assay design rather than be attributed to this compound.
-
Etoposide (VP-16): Practical DNA Damage Workflows
2026-09-25
Use Etoposide (VP-16) to connect topoisomerase II inhibition with DNA double-strand breaks and apoptosis in cancer models. This guide pairs cell-line-aware dose finding with assay design, practical handling advice, and troubleshooting for more interpretable results.
-
Amphotericin B: Mechanism and Research Use
2026-09-24
Amphotericin B is a polyene antifungal antibiotic used in research on fungal membrane integrity and antifungal activity. This overview explains its sterol-dependent mechanism, product-reported benchmarks, and limits when interpreting Candida biofilm or prion-model findings.
-
6-OHDA Hydrochloride: Evidence and Use Boundaries
2026-09-24
6-OHDA hydrochloride is a catecholaminergic neurotoxin used to create experimental lesions in Parkinsonian research models. Its established rationale is distinct from the 25-hydroxycholesterol macrophage pathway described in the supplied Immunity study; the available product dossier does not provide a product-specific protocol.
-
NF-κB–YAP Control of Pyroptosis in Ulcerative Colitis
2026-09-23
A 2026 study links NF-κB p65 activation to LATS1-associated YAP inactivation and increased NLRP3 expression, connecting inflammatory signaling with pyroptosis in ulcerative colitis models. Its cell and mouse experiments suggest that YAP can restrain epithelial pyroptosis, while GSDMD-dependent cell death contributes to colitis severity.
-
A40926 Production Tools in Nonomuraea
2026-09-23
Yushchuk and colleagues developed promoter-reporter tools for genetically recalcitrant Nonomuraea species and used them to identify regulatory strategies for improving A40926 biosynthesis. Overexpression of pathway-specific positive regulators increased production, providing a knowledge-based route to strain improvement and a foundation for future glycopeptide engineering.
-
TCAIM Control of OGDH and Mitochondrial Metabolism
2026-09-22
The reference study identifies TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1, rather than stabilizing or folding the enzyme. These findings establish mitochondrial proteostasis as a post-translational regulator of TCA-cycle activity and carbohydrate catabolism, with implications for interpreting metabolic phenotypes in cells and mice.
-
Ertugliflozin Beyond Glucose: A Translational Playbook
2026-09-22
Ertugliflozin (PF-04971729) illustrates why target selectivity is only the starting point for translational research. This thought-leadership guide connects renal glucose transport, comparative cardioprotection, assay design, and ulcerative colitis research into a practical framework for interpreting mechanism, exposure, and disease-context effects.
-
TCAIM Control of OGDH and Mitochondrial Metabolism
2026-09-21
A 2025 Molecular Cell study identifies TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1. The work expands the role of mitochondrial proteostasis from protein folding to targeted control of a rate-limiting metabolic enzyme, with consequences for OGDH complex activity and carbohydrate catabolism.
-
HOBt in Route Design: From Coupling to SAR
2026-09-21
HOBt (1-Hydroxybenzotriazole) is more than a peptide-coupling additive: it can shape stereochemical control and route reliability in medicinal chemistry. This article examines its mechanism through an indazole glucagon receptor antagonist synthesis and translates the evidence into practical workflow decisions.
-
Bestatin as a Chemical Probe of Jasmonate Signaling
2026-09-20
The reference study established bestatin as a chemical-genetic probe for jasmonic acid signaling in Arabidopsis and tomato, rather than merely an aminopeptidase inhibitor. By combining gene-expression analysis, pathway mutants, developmental phenotyping, and resistant-mutant screening, the authors identified distinct genetic classes that help separate jasmonate perception, response, and bestatin-specific effects.
-
Tetracycline C6589 for Reliable Cell Assays
2026-09-19
Learn how Tetracycline (SKU C6589) can be incorporated into cell viability, proliferation, and cytotoxicity workflows without confusing antibiotic selection effects with biological endpoints. This scenario-based guide covers mechanism, assay controls, DMSO preparation, interpretation, and evidence-based product selection.
-
PTX3–TLR4/NF-κB–FGF21 Axis in Glucocorticoid ONFH
2026-09-18
The reference study identifies PTX3 as a protective regulator of glucocorticoid-induced osteonecrosis of the femoral head and places it upstream of a TLR4/NF-κB/FGF21 signaling axis. Its combination of patient samples, cellular models, knockout mice, recombinant protein rescue, and pathway blockade provides a mechanistic framework for studying impaired osteogenesis and apoptosis in ONFH.
-
Mifepristone (RU486) Experimental Workflows
2026-09-18
Mifepristone (RU486) provides a practical pharmacological switch for testing progesterone receptor-dependent biology in cancer and reproductive models. This guide combines dose planning, receptor-context controls, quantitative readouts, and troubleshooting strategies for more interpretable experiments.
-
Methyl-β-cyclodextrin Protocol and QC Guide
2026-09-17
Methyl-β-cyclodextrin (SKU C6939) is a 98.00% reagent for controlled membrane cholesterol extraction and studies of lipid organization, membrane fluidity, and cholesterol-dependent signaling. It is intended for scientific research only; concentration, exposure time, vehicle, and cell-model compatibility must be established empirically, and prepared solutions should not be stored long term.